Covid-19 and alzheimer’s disease: A literature review

30Citations
Citations of this article
84Readers
Mendeley users who have this article in their library.
Get full text

Abstract

There are a number of potential implications for the field of Alzheimer’s disease (AD) stemming from the global spread of “SARS-COV-2”. Many studies that were conducted by Cleve-land Clinic researchers identified a link between COVID-19 infection and brain abnormalities seen in people with AD. This article explains the association between COVID-19 and AD and how people with AD are affected by COVID-19, whether directly or indirectly. First, this article begins by ex-plaining AD and its types, then giving an overview about COVID-19, its symptoms and the associated complications. Then, direct and indirect consequences of COVID-19 on people experiencing AD are discussed briefly. Some management strategies are recommended at the end of this article in addition to a future perspective on this topic. This article concludes by summarizing the main points mentioned about the association between COVID-19 and AD.

Cite

CITATION STYLE

APA

Hardan, L., Filtchev, D., Kassem, R., Bourgi, R., Lukomska-Szymanska, M., Tarhini, H., … Haikel, Y. (2021, November 1). Covid-19 and alzheimer’s disease: A literature review. Medicina (Lithuania). MDPI. https://doi.org/10.3390/medicina57111159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free